PLASMAPHERESIS IN ACUTE EPISODES OF FULMINANT CNS INFLAMMATORY DEMYELINATION

被引:88
作者
RODRIGUEZ, M [1 ]
KARNES, WE [1 ]
BARTLESON, JD [1 ]
PINEDA, AA [1 ]
机构
[1] MAYO CLIN & MAYO FDN,TRANSFUS MED SECT,ROCHESTER,MN 55905
关键词
D O I
10.1212/WNL.43.6.1100
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We present six patients with acute fulminant episodes of CNS inflammatory demyelination who responded to therapeutic plasmapheresis after failing a course of high-dose methylprednisolone administered IV. Neurologic improvement occurred in three of the patients following the second plasmapheresis. Dramatic improvement in motor function (four patients) and language (two patients) began within 2 to 14 days and persisted during the 6 to 35 months (mean, 15 months) of follow-up. Results of this uncontrolled study suggest that plasmapheresis in the absence of other immunosuppressive drugs may have a role in the treatment of severe episodes of inflammatory demyelination in a select subset of MS patients.
引用
收藏
页码:1100 / 1104
页数:5
相关论文
共 24 条
[1]   QUANTITATIVE MRI CHANGES IN GADOLINIUM-DTPA ENHANCEMENT AFTER HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE IN MULTIPLE-SCLEROSIS [J].
BARKHOF, F ;
HOMMES, OR ;
SCHELTENS, P ;
VALK, J .
NEUROLOGY, 1991, 41 (08) :1219-1222
[2]   INTRAVENOUS METHYLPREDNISOLONE FOR MULTIPLE-SCLEROSIS IN RELAPSE [J].
BARNES, MP ;
BATEMAN, DE ;
CLELAND, PG ;
DICK, DJ ;
WALLS, TJ ;
NEWMAN, PK ;
SAUNDERS, M ;
TILLEY, PJB .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1985, 48 (02) :157-159
[3]   TREATMENT OF ACUTE EXACERBATIONS OF MULTIPLE-SCLEROSIS WITH INTRAVENOUS METHYLPREDNISOLONE [J].
BUCKLEY, C ;
KENNARD, C ;
SWASH, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1982, 45 (02) :179-180
[4]   THE EFFECT OF HIGH-DOSE STEROIDS ON MRI GADOLINIUM ENHANCEMENT IN ACUTE DEMYELINATING LESIONS [J].
BURNHAM, JA ;
WRIGHT, RR ;
DREISBACH, J ;
MURRAY, RS .
NEUROLOGY, 1991, 41 (09) :1349-1354
[5]  
Dau P C, 1991, J Clin Apher, V6, P200, DOI 10.1002/jca.2920060405
[6]   PLASMAPHERESIS IN MULTIPLE-SCLEROSIS - PRELIMINARY FINDINGS [J].
DAU, PC ;
PETAJAN, JH ;
JOHNSON, KP ;
PANITCH, HS ;
BORNSTEIN, MB .
NEUROLOGY, 1980, 30 (10) :1023-1028
[7]   HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE IN THE TREATMENT OF MULTIPLE-SCLEROSIS - CLINICAL-IMMUNOLOGICAL CORRELATIONS [J].
DURELLI, L ;
COCITO, D ;
RICCIO, A ;
BARILE, C ;
BERGAMASCO, B ;
BAGGIO, GF ;
PERLA, F ;
DELSEDIME, M ;
GUSMAROLI, G ;
BERGAMINI, L .
NEUROLOGY, 1986, 36 (02) :238-243
[8]  
KHATRI BO, 1988, NEUROLOGY, V38, P50
[9]   PLASMA-EXCHANGE IN CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS - A LONG-TERM STUDY [J].
KHATRI, BO ;
MCQUILLEN, MP ;
HOFFMANN, RG ;
HARRINGTON, GJ ;
SCHMOLL, D .
NEUROLOGY, 1991, 41 (03) :409-414
[10]   CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS - DOUBLE-BLIND CONTROLLED-STUDY OF PLASMAPHERESIS IN PATIENTS TAKING IMMUNOSUPPRESSIVE DRUGS [J].
KHATRI, BO ;
MCQUILLEN, MP ;
HARRINGTON, GJ ;
SCHMOLL, D ;
HOFFMANN, RG .
NEUROLOGY, 1985, 35 (03) :312-319